Literature DB >> 14713800

Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.

Ekkehard W Hauck1, Ulrich O Mueller, Thomas Bschleipfer, Hans U Schmelz, Thorten Diemer, Wolfgang Weidner.   

Abstract

PURPOSE: Extracorporeal shock wave therapy (ESWT) for the treatment of Peyronie's disease is still controversial. This exploratory meta-analysis of published studies in the international literature investigates its therapeutic effects.
MATERIALS AND METHODS: The treatment outcomes from 17 study groups identified by a computerized literature search were compared with natural history outcomes and data from control groups from 2 controlled ESWT studies. An exploratory meta-analysis was performed because a methodologically sound meta-analysis lege artis did not appear appropriate, since treated groups differ considerably in structure, the selection of outcome measures is inconsistent and measurement is not standardized.
RESULTS: ESWT seems to have an effect on penile pain during erection and on the improvement of sexual function. Pain seems to resolve faster after ESWT than during the course of the natural history. The effect on plaque size and penile curvature is less impressive.
CONCLUSIONS: ESWT in Peyronie's disease at least seems to be effective in regard to penile pain and sexual function compared to natural history. Deducing from these data the effect on plaque size and curvature remains questionable. However, ESWT is not an evidence based therapy at present. A controlled (preferably pairwise matched), single blind, multicenter study with careful, detailed documentation of disease symptoms before intervention and of outcomes is required to evaluate the real effect of ESWT.

Entities:  

Mesh:

Year:  2004        PMID: 14713800     DOI: 10.1097/01.ju.0000108060.30363.8d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  [Significance of extracorporeal shock-wave therapy (ESWT) in plastic penile induration. Statement of the DGU].

Authors:  W Weidner; E W Hauck
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

2.  [Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Authors:  E W Hauck; T Bschleipfer; S M Haag; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

Review 3.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 4.  [Peyronie's disease. Conservative and surgical therapy].

Authors:  E W Hauck; T Diemer; W Weidner
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

Review 5.  2013-2014 updates in Peyronie's disease management.

Authors:  Benjamin A Sherer; Krishnan Warrior; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

6.  Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study.

Authors:  Farzad Allameh; Mohammadreza Razzaghi; Seyed Mansoor Rayegani; Morteza Fallah-Karkan; Arash Ranjbar; Amirhosein Rahavian; Atefeh Javadi; Saleh Ghiasy; Zahra Razzaghi
Journal:  J Lasers Med Sci       Date:  2019-12-01

Review 7.  Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?

Authors:  Mikkel Fode; Georgios Hatzichristodoulou; Ege Can Serefoglu; Paolo Verze; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2017-07-25       Impact factor: 14.432

8.  A Critical Analysis of Reporting in Systematic Reviews and Meta-Analyses in the Peyronie's Disease Literature.

Authors:  Raevti Bole; Harrison Chase Gottlich; Matthew J Ziegelmann; Dillon Corrigan; Laurence A Levine; John P Mulhall; Petar Bajic
Journal:  J Sex Med       Date:  2022-02-15       Impact factor: 3.937

Review 9.  A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.

Authors:  L Gao; S Qian; Z Tang; J Li; J Yuan
Journal:  Int J Impot Res       Date:  2016-06-02       Impact factor: 2.896

Review 10.  Conservative management options for Peyronie's disease.

Authors:  Gregory S Jack; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.